Adding Sentry Score to the Philips Suite of Acute Care performance applications builds upon currently available algorithms that target early deterioration detection, patient discharge readiness scoring, clinician workflow productivity and acuity-based population health prioritization. This addition further demonstrates Philips' commitment to developing solutions with predictive analytics and artificial intelligence that aim to help health systems achieve the quadruple aim of value-based healthcare: an improved experience for patients and staff, better health outcomes and a lower cost of care. Through these risk scores, Philips' comprehensive solutions, like eCareManager, provide clinicians in the tele-ICU with a more comprehensive view of the patient, allowing them to coordinate assessments and recommended actions with the bedside care team in an efficient, less disruptive way.

Philips eCareManager, including Sentry Score, is currently available in the U.S., the UK, Japan, Australia and the Middle East. The solution is also being deployed across U.S.-based IDNs, showing momentum and adoption of the benefits this telehealth solution delivers. Additional information on Philips' telehealth solutions is available here.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries.

Back to HCB News

Health IT Homepage